Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1

9(75.0%)

Phase 2

2(16.7%)

N/A

1(8.3%)

12Total

Phase 1(9)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT03057756Completed

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Role: collaborator

NCT06239337Completed

Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children

Role: collaborator

NCT05929157Phase 1Unknown

A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate

Role: collaborator

NCT02287480Phase 1Completed

VSV-ZEBOV Geneva Vaccine Trial

Role: collaborator

NCT00331136Phase 2Completed

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Role: collaborator

NCT02450578Phase 1Completed

DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

Role: collaborator

NCT02704533Phase 1Completed

Sequential Optimization of Dose and Schedule of PfSPZ Vaccine

Role: collaborator

NCT03093129Phase 2Unknown

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)

Role: collaborator

NCT02283099Phase 1Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Role: collaborator

NCT02115516Phase 1Completed

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

Role: collaborator

NCT02296983Phase 1Unknown

A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.

Role: collaborator

NCT01624961Phase 1Completed

Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

Role: collaborator

NCT02237586Phase 1Completed

Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge

Role: collaborator

NCT00811421Not ApplicableCompleted

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

Role: collaborator

All 14 trials loaded